iLite® ADCC Target mVEGF (+) Assay Ready Cells can be used for assessing the possibility of an anti-VEGF antibody drug inducing ADCC.
iLite mVEGF (+) Target Assay Ready Cells are based on a human embryonic kidney cell line, HEK2931 (ATCC# CRL-1573), and have been genetically engineered and optimized to express high and constant levels of membrane bound VEGF. The cells are to be used as target cells together with iLite® ADCC Effector (V) Assay Ready Cells for measuring the ADCC activity of anti-VEGF antibodies.
* The HEK-293 cell line has been used under a license obtained from AdVec Inc.
FOR RESEARCH USE ONLY
|Size||1 vial corresponding to one 96 well plate|
|Technology||Cell-based reporter gene assay|
|Read-out of results||Quantitative,|
|Regulatory status||Research Use Only|
>250 μL of Assay Ready Cells suspended in cryoprotective medium from Gibco (cat no 12648-010)
Get access to scientific material, posters and more.